Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome

Gut and Liver

Volumn 3, Issue 1, 2009, Pages 26-30

  Park, Seon Young ^a   Park, Min Ho ^b   Yoon, Kyoung Won ^a   Cho, Sung Bum ^a   Lee, Wan Sik ^a   Park, Chang Hwan ^a   Kim, Hyun Soo ^a   Choi, Sung Kyu ^a   Rew, Jong Sun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Philip Medical Center   (South Korea)

Author keywords

5 hydroxytryptamine; Irritable bowel syndrome; Psychopathology

Indexed keywords

CARBOHYDRATE; SEROTONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; IRRITABLE COLON; MALE; MENTAL DISEASE; PSYCHOLOGIC ASSESSMENT; SEROTONIN BLOOD LEVEL; SYMPTOM CHECKLIST 90; THROMBOCYTE POOR PLASMA;

EID: 67249141848     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2009.3.1.26     Document Type: Article

References (28)

1. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580.
2. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123: 2108-2131.
3. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95: 701-708.
4. Whitehead WE, Bosmajian L, Zonderman AB, Costa PT Jr, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome: comparison of community and medical clinic samples. Gastroenterology 1988;95: 709-714.
5. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000;95: 67-71.
6. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000;95: 2698-2709.
7. Snape WJ Jr, Matarazzo SA, Cohen S. Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity. Gastroenterology 1978;75: 373-378.
8. Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology 1991;101: 373-381.
9. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998;42: 42-46.
10. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxy- tryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003;52: 663-670.
11. Kim JJ. Serotonin, stress, and conditioning. Biol Psychiatry 2008;63: 819-820.
12. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:II43-47.
13. Dursun SM, Szemis A, Andrews H, Whitaker P, Reveley MA. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study. J Psychiatry Neurosci 2000;25: 347-352.
14. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry 1976;128: 280-289.
15. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS): patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998;10: 415-421.
16. Simren M, Mansson A, Langkilde AM, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63: 108-115.
17. Zuo XL, Li YQ, Yang XZ, et al. Plasma and gastric mucosal 5-hydroxytryptamine concentrations following cold water intake in patients with diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol 2007;22: 2330-2337.
18. Pan H, Gershon MD. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 2000;20: 3295-3309.
19. Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/ 5-HT1p receptors on sensory CGRP neurons. Am J Physiol 1996;270:G778-782.
20. Gershon MD. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999;13 Suppl 2: 15-30.
21. Da Prada M, Tranzer JP, Pletscher A. Storage of 5-hydroxytryptamine in human blood platelets. Experientia 1972;28: 1328-1329.
22. Tyce GM, Rorie DK, Byer DE, Danielson DR. Free and conjugated amines in human lumbar cerebrospinal fluid. J Neurochem 1985;44: 322-324.
23. Warner RR. Hyperserotoninemia in functional gastrointestinal disease. Ann Intern Med 1963;59: 464-470.
24. Irvine EJ. Quality of life issues in patients with inflammatory bowel disease. Am J Gastroenterol 1997;92:18S-24S.
25. Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut 2000;47: 444-454.
26. Whitehead WE, Burnett CK, Cook EW 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996;41:2248-2253.
27. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119: 654-660.
28. Locke GR 3rd, Weaver AL, Melton LJ 3rd, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004;99: 350-357.